APA
IRWD icon

American Portfolios Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

American Portfolios Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$900 – 3044
2020
Q3 		$900 Hold
100
– – ﹤0.01% 2783
2020
Q2 		$1.03K Hold
100
– – ﹤0.01% 2677
2020
Q1 		$1.01K Sell
100
-100
-50% -$1.18K ﹤0.01% 2562
2019
Q4 		$2.66K Buy
+200
New +$2.21K ﹤0.01% 2492

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

American Portfolios Advisors's IRWD Position: Q4 2020 in Review

American Portfolios Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2020, closing a stake of 100 shares — an estimated $900 sold.

American Portfolios Advisors first reported a position in IRWD in Q4 2019 and held it in 4 quarters. The position peaked at $2.66K in Q4 2019. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2020.

  • American Portfolios Advisors reported no remaining Ironwood Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 100 Ironwood Pharmaceuticals shares in Q4 2020, an estimated $900.
  • American Portfolios Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • American Portfolios Advisors's Ironwood Pharmaceuticals position peaked at $2.66K in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2020.

Based on American Portfolios Advisors's 13F filing for Q4 2020, filed 22 Mar 2023.